Nuwellis Inc vs Oxford Lane Capital Corp — how do they compare? Nuwellis Inc trades at $1.49 (market cap $542.80K), while Oxford Lane Capital Corp trades at $9.36 (market cap $909.61M). The key difference: Oxford Lane Capital Corp is far larger — about 1675.8× Nuwellis Inc's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | OXLC | |
|---|---|---|
Market Cap | $542.80K | $909.61M |
Sector | Technology | Financials |
52-Week High | $220.50 | $18.75 |
52-Week Low | $1.42 | $8.15 |
Enterprise Value | -$1.27M | — |
Dividend Yield | — | 25.76% |
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →